ChemInform Abstract: Prospects for Improved Antidepressants (original) (raw)

Committee for Medicinal Products for Human Use (CHMP) assessment on efficacy of antidepressants

Karl Broich

European Neuropsychopharmacology, 2009

View PDFchevron_right

Current approaches to the drug treatment of depression

Alexander Galloway

2003

View PDFchevron_right

Emerging targets for antidepressant therapies

charles nemeroff

Current Opinion in Chemical Biology, 2009

View PDFchevron_right

Conventional and new antidepressant drugs in the elderly

Pietro Gareri

Progress in Neurobiology, 2000

View PDFchevron_right

Novel Antidepressant Drugs, Arterial Hypertension and Cardiovascular Disease

Georgia Vamvakou

Recent Patents on Cardiovascular Drug Discovery, 2014

View PDFchevron_right

Mechanism of Actions of Antidepressants: Beyond the Receptors

Ali Saffet Gonul

Bulletin of Clinical Psychopharmacology

View PDFchevron_right

Today’s psychopharmacological treatments: results, problems, new perspectives

Selim Kiliç

Bulletin of Clinical Psychopharmacology, 2012

View PDFchevron_right

A schematic representation of the psychopharmacological profile of antidepressants

Michel Bourin

Progress in Neuro-Psychopharmacology and Biological Psychiatry, 1996

View PDFchevron_right

Comparative Benefits and Harms of Second-Generation Antidepressants for Treating Major Depressive Disorder

Susan Gaylord

Annals of Internal Medicine, 2011

View PDFchevron_right

Psychotropic Drug Considerations in Depressed Patients with Metabolic Disturbances

M Hasnain

The American Journal of Medicine, 2008

View PDFchevron_right

Drug Therapy for Geriatric Depression

Michael Katz

Drugs & Aging, 1993

View PDFchevron_right

Prevalence of Prescription Medications With Depression as a Potential Adverse Effect Among Adults in the United States

Dima Qato

JAMA, 2018

View PDFchevron_right

LC-MS Analysis of Serotonergic Drugs

Iain M. McIntyre, Ph.D.

Journal of Analytical Toxicology, 2003

View PDFchevron_right

Maraula et al. Neuropharmacol. 2012

Felicita Pedata

View PDFchevron_right

Psychotropic medications affecting biological rhythm

Yavuz Selvi

Journal of Mood Disorders, 2011

View PDFchevron_right

IPS multicentric study: Antidepressant prescription patterns

Kamal N Kalita

Indian Journal of Psychiatry, 2013

View PDFchevron_right

Metabolic side-effects of novel antipsychotic drugs

Darko Marčinko

Biochemia Medica, 2007

View PDFchevron_right

Paroxetine Versus Placebo and Other Agents for Depressive Disorders

Pierre Bleau

The Journal of Clinical Psychiatry, 2007

View PDFchevron_right

Benefits of different drug formulations in psychopharmacology

Henderik W . Frijlink

European Neuropsychopharmacology, 2003

View PDFchevron_right

Dependence potential of antidepressants compared to benzodiazepines

Cornelis Kan

Progress in Neuro-Psychopharmacology and Biological Psychiatry, 2002

View PDFchevron_right

Neuropharmacological Screening and isolation of

Paul Nwafor

2012

View PDFchevron_right

Psychotropic Medications in the Elderly

Jason Strauss

Manual of Geriatric Anesthesia, 2012

View PDFchevron_right

Resurgence of Long-Acting Antipsychotic Formulations

Steven Siegel

Current Psychiatry Reports, 2010

View PDFchevron_right

Antidepressants as Long-Acting Local Anesthetics

Danja Groves

Regional Anesthesia and Pain Medicine, 2004

View PDFchevron_right

11th National Meeting of Organic Chemistry and 4th Meeting of Therapeutic Chemistry

Maria Luísa Cardoso do Vale

Pharmaceuticals, 2016

View PDFchevron_right

Antipsychotic Drugs

Melissa Piasecki

Encyclopedia of Substance Abuse Prevention, Treatment, & Recovery

View PDFchevron_right

Psychotropic drug use in patients with various chronic somatic diseases

Hugo Smeets

The European Journal of Psychiatry, 2012

View PDFchevron_right

Abstracts Second Congress of the European Society for Clinical Neuropharmacology

A. Seghers

Journal of Neural Transmission, 1995

View PDFchevron_right

Population scale data reveals the antidepressant effects of ketamine and other therapeutics approved for non-psychiatric indications

Rabia Atayee

Scientific Reports, 2017

View PDFchevron_right

Antidepressant Treatment and Risk of Dementia

Cynthia Lee

The Journal of Clinical Psychiatry, 2016

View PDFchevron_right

International Journal of Pharmaceutical Chemistry and Analysis

Indra Tripathi

View PDFchevron_right

Handbook of Pharmaceutical excipients

Montse Covet

View PDFchevron_right

Pharmacological Agents in the Treatment of Anxiety Disorders

Emman Ramos

Indian Journal of Psychological Medicine, 1989

View PDFchevron_right

Antidepressant use in elderly medical inpatients

Frank Shelp

Journal of General Internal Medicine, 1989

View PDFchevron_right

Journal of Population Therapeutics & Clinical Pharmacology

Ledi Necaj

View PDFchevron_right